Statistical analysis of a limiting dilution assay (LDA) Louis, Mo.) per ml, and 10-IU of goat antiserum against alpha interferon (Janssen, Beerse, Belgium) per ml as previously described in detail (2). Half of the culture medium was replaced after 72 h and every 48 h thereafter. The supernatants removed from the cultures were tested by enzymelinked immunosorbent assay (ELISA) (Abbott, Chicago, Ill.) for the presence of p24 antigen until day 29 for all-or-nothing (positive or negative) results. Cultures were considered positive if they contained more than 50 pg of p24 antigen per ml, which is the limit of sensitivity for this p24 detection kit.
[CDC] group II/III), patients with AIDS-related complex (CDC group IVa), and patients with AIDS (CDC group Nb/c), respectively. A nearly 10-fold disparity in mean frequencies was observed when these values were correlated with the numbers of CD4-positive cells (1/9,000, 1/1,500, and 1/300, respectively, for asymptomatic patients, patients with AIDS-related complex, and patients with AIDS). The described method provides a simple means of determining infectious HIV-1-positive cells in blood samples.
Endpoint or limiting dilution assays (LDAs) are commonly used for the determination of the frequency of human immunodeficiency virus type 1 (HIV-1) infectious cells (for a review, see reference 1). Reliable estimations of the number of virus-producing cells can be ensured when we assume that one or more infectious cells at the endpoint will result in detectable viral production, while no response will occur in the absence of infectious cells. The probability of finding a single HIV-1 cell at the limiting dose fit the pattern of a single-hit Poisson distribution (11, 17 Louis, Mo.) per ml, and 10-IU of goat antiserum against alpha interferon (Janssen, Beerse, Belgium) per ml as previously described in detail (2) . Half of the culture medium was replaced after 72 h and every 48 h thereafter. The supernatants removed from the cultures were tested by enzymelinked immunosorbent assay (ELISA) (Abbott, Chicago, Ill.) for the presence of p24 antigen until day 29 for all-or-nothing (positive or negative) results. Cultures were considered positive if they contained more than 50 pg of p24 antigen per ml, which is the limit of sensitivity for this p24 detection kit.
Statistical analysis of LDA. Frequency estimations of LDA data were performed by the method described by Taswell (17) . By this method, the estimates for a single infectious cell in a given culture are more precise than estimates obtained by the least-squares method and are simpler and less cumbersome than methods based on likelihood maximization or x2 minimization (11) . The then there is the probability P(x) = ficC e-x/ic that a culture receives a number of infectious HIV-1-positive cells (ic), and f is the estimate of the true frequency. The probability that a viral culture is negative [Pneg(x)] is then equal to Pneg(X) = ef. On the basis of this equation, one can calculate the probability that a culture will receive only one infectious cell (i.e., f = 1). Accordingly, Pneg(X) = e-= 0.37. Therefore, 37% of negative cultures for a given dilution of cell population x will correspond to a dose in which there is a single HIV-1-producing cell per well.
Quantitative viral coculture. The following technique was applied to all patients whose data are reported here. PBMCs from 57 subjects, including 38 asymptomatic subjects, 10 patients with ARC, and 9 patients with AIDS, were separated over Ficoll-Hypaque and were stored in liquid nitrogen until use. Before coculture, PBMC samples were thawed, tested for viability, and resuspended in viral culture medium at a concentration of 108 cells per ml. An equal number of washed phytohemagglutinin-stimulated blast cells (106/ml) from donor B was added, and the cocultures were continued in capped polypropylene tubes (12 by 75 mm) in a final volume of 2 ml. Each coculture was duplicated. The PBMCs from seronegative donors were used as negative controls. Seventy-two hours later and every 48 h thereafter, half of the coculture supernatant was removed for analysis and was replaced with the same volume of fresh culture medium. The supernatants were evaluated by ELISA for their p24 antigen content. The time when viral production reached 1 ng of p24 antigen per ml was registered. (17) .
Correlation between the frequency of infectious HIV-1-positive cells and the time when viral production reaches 1 ng of p24 per ml. A linear relationship was obtained when frequencies of infectious cells in all six patients were drawn on the vertical axis and the time (in hours) when the viral culture reached 1 ng of p24 per ml was drawn on horizontal axis. Figure 2 shows a direct relationship between the number of infectious cells and viral production. Although this phenomenon is not new by itself, it appeared that this relationship could be expressed mathematically. Regression analysis showed that the correlation between the occurrence of HIV-1-positive cells and the onset of viral production was highly accurate (r = 0.957; P < 0.01) for the first 360 h (15 days) of viral culture. Beyond that period no straight relationship was observed, and the results needed to be extrapolated by using a 2-day back-shift on real time. However, a linear relationship obtained within a reliable 2-week time span can be expressed by the following formula: f(ic) = 2,370 x 1.3335004o, wheref(ic) is the frequency of infectious virus-carrying cells, and t is the number of hours necessary to obtain 1 ng of p24 antigen per ml in the supernatant of the coculture. Frequency estimates in clinical specimens. A total of 57 subjects (38 asymptomatic, 10 with ARC, and 9 with AIDS) were selected from our outpatient clinic, and their blood samples were used for determination of cell-associated viral load by the quantitative viral coculture method described above. The mean frequencies of infectious cells were correlated with the advancement in the clinical stage, being 1/38,000, 1/11,000, and 1/7,000 for asymptomatic patients (Centers for Disease Control [CDC] group II/III), patients with ARC (CDC group IV a), and patients with AIDS (CDC group IV b/c), respectively. When these values were correlated with the numbers of CD4-positive cells, we obtained significant disparities in frequencies (1/9,000, 1/1,500, and 1/300) between each group of patients, that is, asymptomatic subjects, patients with ARC, and patients with AIDS, respectively (Table 1) . DISCUSSION We established that the frequency of HIV-1-positive cells is in a linear relationship with the time when viral coculture generates 1 ng of p24 antigen per ml, or an equivalent of 107 virions per ml (4) . A simple duplicate coculture of 106 PBMCs from normal donors with an equivalent number of PBMCs from HIV-1-infected individuals is less cumbersome than LDA and can be applied on a routine basis to detect a single virus-carrying cell among as many as 320,000 PBMCs or within a range of 56 to 112,800 CD4-positive cells. If necessary, the limits of this range can be overcome by adjustment (decreasing or increasing) of the ratio of cells. However, from a practical point of view, our 1:1 working ratio of donor and test cells appears to be sufficient to cover a broad range of frequencies and to distinguish between the main clinical stages of HIV-1 infection. Although the use of target PBMCs from different donors may lead to some discrepancy in the time required to reach 1 ng of p24, it appeared that this variation can be decreased by pooling donors' PBMCs without affecting the intertest variability.
Many types of viral quantitation techniques, including LDA, were described for establishing viral load in plasma or PBMCs from infected individuals. However, for different reasons, all of these techniques have distinct shortcomings (for a review, see reference 1). Although the convenience of our method is also limited, it is, however, much less laborious than LDA, while the frequency estimates obtained from duplicate cocultures are highly accurate and reproducible.
According to our recent observation (13), primary HIV-1 isolates derived from a wide variety of clinical sources behaved similarly in an assay designed to measure their kinetics of replication. This implies that the infectious property of HIV-1 does not change throughout all stages of the infection. It is therefore possible that the estimations of HIV-1 burden in the blood of patients by our method can be valid independently of the patient's clinical status or geographical origin. Using viral quantitative coculture, we confirmed that the increase in viral load is associated with the evolution of HIV-1 infection (13) (14) (15) (16) 18) . It was originally believed that HIV-1-infected cells are found at a very low frequency (1 in 100,000 cells) in peripheral blood (9) . Later it was demonstrated, however, that the occurrence of virusinfected cells in HIV-1-seropositive individuals is at least 1 in 100 to 1,000 circulating mononuclear cells (2, 3, 5-8, 10, 14-16) . Results of those studies and a recent study that used confocal microscopy (12) claimed that the frequency of HIV-1-carrying cells in the blood of infected individuals is higher than that estimated initially (9) . However, until now, there were no large-scale studies that attempted to establish precisely whether such broad, 3-log1o-unit differences between the results of various studies were true. Results of our study suggest that all earlier frequency estimates are within a plausible range and that the discrepancies among these studies were mainly due to the diversity between both infected individuals and clinical groups of patients. For example, in the PBMCs from our asymptomatic group, we observed nearly 100-fold differences in PBMC numbers between individuals (frequency range, 1 in 5,600 to 1 in 320,000). The mean numbers of infectious HIV-1-harboring cells in PBMCs from each clinical group (asymptomatic subjects and patients with ARC and AIDS) were clearly distinct. Moreover, this difference was even more pronounced when the numbers of HIV-1-positive cells were adjusted against CD4 counts. On the basis of this observation, it appeared that the transition from one clinical stage of HIV-1 infection to another is accompanied by a nearly 10-fold increase in viral load. In addition, evaluation of the frequency of HIV-1-infected cells based on CD4 counts, rather than on PBMC numbers, yields a more precise, clear-cut distinction between disease stages since the overlapping of frequency ranges appears to be minimal (Table 1) . Our recent longitudinal studies indicated that contrary to plasma viremia, the cell-associated viral load in a given asymptomatic individual remains relatively stable and does not vary from one measurement to another unless there is a progression to the next clinical stage of HIV-1 infection (2, 18) . We have also shown that the use of the described quantitative viral coculture may reveal a trend for clinical deterioration as early as 14 months in advance (2).
In conclusion, results of our study demonstrate a linear relationship between the frequency of infectious HIV-1-harboring cells in the blood of patients and the time required to generate 1 ng of p24 antigen per ml in viral cocultures. This finding forms the experimental basis for a simple viral quantitation test that could be applied to therapeutic and prognostic studies.
